Study of the Effects of Acute Exposure to Moderate Altitude Hypoxia on Prospective Memory. (HYPRO)
9 de mayo de 2026 actualizado por: Direction Centrale du Service de Santé des Armées
Etude Des Effets d'Une Exposition aiguë à l'Hypoxie d'Altitude modérée Sur la mémoire Prospective (HYPRO)
The goal of this study is to investigate whether prospective memory, i.e., memory for delayed intentions, is impaired at moderate altitude (4,000m).
It will also allow to study the effect of air and oxygen administration during hypoxia exposure.
The main questions it aims to answer are:
- Does moderate acute hypoxia impair prospective memory ?
- If so, does air or oxygen adminsitration induce a restoration of prospective memory? Researchers will compare cognitive performance during normobaric hypoxia exposure to cognitive performance during normoxia (control situation).
Participants will:
- Session S0. Perform a battery of neuropsychological tests and questionnaires). EEG will be recorded during tests. A cheek swab will be performed.
- Sessions S1 and S2. Perform several cognitive tasks while exposed to hypoxia and to normoxia (2 different sessions, randomized order) in a normobaric chamber. These are standardized cognitive tests administered on a computer and cognitive tests embedded in a flight simulator scenario. Various questionnaires will be performed on a regular basis. Several physiological measurements will be performed continuously: EEG, ECG, SpO2 and breathing rate. Blood pressure will be measured at the beginning and at the end of hypoxia/normoxia exposure. A blood sample will also be performed. At last, participants will inhale air or oxygen through a mask while making a cognitive task in the chamber.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Descripción detallada
Flight crew operate in a dynamic, complex, and uncertain environment that requires them to process a large amount of information from multiple sources under time pressure. To successfully carry out their mission, flight crews must therefore constantly sort, prioritize, and analyze relevant information based on the situation, which requires them to manage their cognitive resources simultaneously-at the risk of experiencing a decline in performance that could significantly compromise aviation safety.
With recent changes in the geostrategic context, the flight profiles of operational missions expose military aircraft crews and onboard operators to a greater risk of in-flight hypoxia. During an acute hypoxic episode, physiological cardiac and respiratory responses are triggered to protect the body-and particularly the brain-from oxygen deprivation. However, these mechanisms are effective only for a limited time. If normoxia is not restored, symptoms will manifest as hypoxemia worsens.
Among flight crew members, impairments in cognitive functions-particularly prospective memory-such as failing to report one's position to other aircraft or failing to retract the flaps before takeoff, are common and can lead to serious accidents. To our knowledge, the effects of hypoxic exposure on this form of memory have not yet been investigated.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
50
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Carine MALLE, PhD
- Número de teléfono: 33 178651479
- Correo electrónico: carine.malle@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Fabien SAUVET, MD, PhD
- Correo electrónico: fabien.sauvet@gmail.com
Ubicaciones de estudio
-
-
-
Brétigny-sur-Orge, Francia, 91220
- Institut de Recherche Biomédicale des Armées
-
Contacto:
- Fabien SAUVET, MD, PhD
- Correo electrónico: fabien.sauvet@gmail.com
-
Contacto:
- Carine MALLE, Phd
- Correo electrónico: carine.malle@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Healthy volunteer
- Has provided informed consent
Exclusion Criteria:
- Individuals who do not understand French
- Pregnant or breastfeeding women
- Cardiovascular risk factor
- Infectious disease within the last 4 weeks
- Chronic cardiovascular, respiratory, hematological, neurological, psychiatric, or metabolic disease
- History of epileptic seizures, convulsions, or loss of consciousness
- Individuals with migraines
- History of a bleeding disorder
- History of high blood pressure
- Current medication use (excluding contraception)
- History of episodes of altitude intolerance
- Stay at high altitude (> 3,500 m) within the last 3 months
- Anxiety score on the Hospital Anxiety and Depression (HAD) scale > 7
- Depression score on the HAD scale > 7
- Uncontrollable claustrophobia or a history of panic attacks
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Normoxia-Air + Hypoxia-Air
S1 = Normoxia exposure + air administration S2 = Hypoxia exposure + air administration
|
Normobaric hypoxia exposure (FiO2 = 12,6%, equivalent to 4,000m) during 4h
Air administration (Fi02 = 21%) through a mask during 10 minutes
Auditory oddball, visual oddball, event-based prospective memory, time-based prospective memory, n-back.
EEG, ECG, SpO2, breathing rate, eyetracking, blood pressure
A blood sample is collected for mitochondrial breathing analyses
Event-based prospective memory and time-based prospective memory.
Prepar3D flight simulator.
|
|
Experimental: Hypoxia-Air + Normoxia-Air
S1 = Hypoxia exposure + air administration S2 = Normoxia exposure + air administration
|
Normobaric hypoxia exposure (FiO2 = 12,6%, equivalent to 4,000m) during 4h
Air administration (Fi02 = 21%) through a mask during 10 minutes
Auditory oddball, visual oddball, event-based prospective memory, time-based prospective memory, n-back.
EEG, ECG, SpO2, breathing rate, eyetracking, blood pressure
A blood sample is collected for mitochondrial breathing analyses
Event-based prospective memory and time-based prospective memory.
Prepar3D flight simulator.
|
|
Experimental: Normoxia-O2 + Hypoxia-O2
S1 = Normoxia exposure + oxygen administration S2 = Hypoxia exposure + oxygen administration
|
Normobaric hypoxia exposure (FiO2 = 12,6%, equivalent to 4,000m) during 4h
Auditory oddball, visual oddball, event-based prospective memory, time-based prospective memory, n-back.
EEG, ECG, SpO2, breathing rate, eyetracking, blood pressure
A blood sample is collected for mitochondrial breathing analyses
Event-based prospective memory and time-based prospective memory.
Prepar3D flight simulator.
Oxygen administration (FiO2 = 100%) through a mask during 10 minutes
|
|
Experimental: Hypoxia-O2 + Normoxia-O2
S1 = Hypoxia exposure + oxygen administration S2 = Normoxia exposure + oxygen administration
|
Normobaric hypoxia exposure (FiO2 = 12,6%, equivalent to 4,000m) during 4h
Auditory oddball, visual oddball, event-based prospective memory, time-based prospective memory, n-back.
EEG, ECG, SpO2, breathing rate, eyetracking, blood pressure
A blood sample is collected for mitochondrial breathing analyses
Event-based prospective memory and time-based prospective memory.
Prepar3D flight simulator.
Oxygen administration (FiO2 = 100%) through a mask during 10 minutes
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in event-based prospective memory accuracy between hypoxia and normoxia conditions
Periodo de tiempo: Through study completion, an average of 1 month
|
Accuracy (%) = Prospective memory target detection rate (number of targets correctly responded to / total number of targets presented × 100)
|
Through study completion, an average of 1 month
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
6 de mayo de 2026
Finalización primaria (Estimado)
31 de diciembre de 2026
Finalización del estudio (Estimado)
31 de diciembre de 2026
Fechas de registro del estudio
Enviado por primera vez
30 de abril de 2026
Primero enviado que cumplió con los criterios de control de calidad
9 de mayo de 2026
Publicado por primera vez (Actual)
13 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
13 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
9 de mayo de 2026
Última verificación
1 de abril de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades Cerebrales
- Enfermedades del Sistema Nervioso Central
- Enfermedades del Sistema Nervioso
- Enfermedades de las vías respiratorias
- Trastornos de la respiración
- Signos y Síntomas Respiratorios
- Condiciones Patológicas, Signos y Síntomas
- Signos y síntomas
- Hipoxia
- Hipoxia, Cerebro
- Vertigo
- Técnicas de investigación
- Manejo de muestras
- Técnicas de laboratorio clínico
- Técnicas y procedimientos de diagnóstico
- Diagnóstico
- Puntas
- Procedimientos quirúrgicos, operativo
- Químicos inorgánicos
- Elementos
- Calcógenos
- Gases
- Oxígeno
- Recolección de muestras de sangre
Otros números de identificación del estudio
- 2026-A00082-49 (Otro identificador: ANSM)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .